Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Trial · NCT00378703
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Arm A (Bevacizumab) | 89 | |
| Overall Study | STARTED | Arm B (Bevacizumab and Temsirolimus) | 91 | |
| Overall Study | STARTED | Arm C (Bevacizumab and Sorafenib) | 90 | |
| Overall Study | STARTED | Arm D (Sorafenib and Temsirolimus) | 91 | |
| Overall Study | Treated | Arm A (Bevacizumab) | 88 | |
| Overall Study | Treated | Arm B (Bevacizumab and Temsirolimus) | 86 | |
| Overall Study | Treated | Arm C (Bevacizumab and Sorafenib) | 90 | |
| Overall Study | Treated | Arm D (Sorafenib and Temsirolimus) | 91 | |
| Overall Study | Eligible and Treated | Arm A (Bevacizumab) | 84 | |
| Overall Study | Eligible and Treated | Arm B (Bevacizumab and Temsirolimus) | 80 | |
| Overall Study | Eligible and Treated | Arm C (Bevacizumab and Sorafenib) | 83 | |
| Overall Study | Eligible and Treated | Arm D (Sorafenib and Temsirolimus) | 84 | |
| Overall Study | COMPLETED | Arm A (Bevacizumab) | 0 | |
| Overall Study | COMPLETED | Arm B (Bevacizumab and Temsirolimus) | 0 | |
| Overall Study | COMPLETED | Arm C (Bevacizumab and Sorafenib) | 0 | |
| Overall Study | COMPLETED | Arm D (Sorafenib and Temsirolimus) | 0 | |
| Overall Study | NOT COMPLETED | Arm A (Bevacizumab) | 89 | |
| Overall Study | NOT COMPLETED | Arm B (Bevacizumab and Temsirolimus) | 91 | |
| Overall Study | NOT COMPLETED | Arm C (Bevacizumab and Sorafenib) | 90 | |
| Overall Study | NOT COMPLETED | Arm D (Sorafenib and Temsirolimus) | 91 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00378703/flow